Edition:
United Kingdom

Santen Pharmaceutical Co Ltd (4536.T)

4536.T on Tokyo Stock Exchange

1,693JPY
23 Feb 2018
Change (% chg)

¥-15 (-0.88%)
Prev Close
¥1,708
Open
¥1,711
Day's High
¥1,720
Day's Low
¥1,691
Volume
800,100
Avg. Vol
1,298,682
52-wk High
¥1,946
52-wk Low
¥1,463

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold 20.66 March 24 Feb 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 1
(2) OUTPERFORM 4 4 4 4
(3) HOLD 6 6 6 5
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.73 2.73 2.73 2.55

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 1 55,000.00 55,000.00 55,000.00 --
Quarter Ending Sep-18 1 54,900.00 54,900.00 54,900.00 --
Year Ending Mar-18 10 221,191.00 226,513.00 206,000.00 209,656.00
Year Ending Mar-19 10 229,487.00 237,270.00 212,000.00 217,888.00
Earnings (per share)
Quarter Ending Jun-18 1 20.66 20.66 20.66 --
Quarter Ending Sep-18 1 20.42 20.42 20.42 --
Year Ending Mar-18 11 76.18 80.42 70.60 69.86
Year Ending Mar-19 11 75.28 83.22 60.30 77.40
LT Growth Rate (%) 2 10.33 13.27 7.40 -12.35

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-17 58,288.70 57,818.00 470.67 0.81
Quarter Ending Sep-17 52,350.70 54,825.00 2,474.33 4.73
Quarter Ending Jun-17 52,734.00 55,949.00 3,215.00 6.10
Quarter Ending Mar-17 51,473.00 48,429.00 3,044.00 5.91
Quarter Ending Dec-16 52,375.00 52,838.00 463.00 0.88

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 55,000.00 55,000.00 55,000.00 55,000.00 --
Quarter Ending Sep-18 54,900.00 54,900.00 54,900.00 54,900.00 --
Year Ending Mar-18 221,191.00 220,871.00 219,891.00 219,331.00 209,656.00
Year Ending Mar-19 229,487.00 228,847.00 228,357.00 228,096.00 217,888.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 0 0
Quarter Ending Sep-18 0 0 0 0
Year Ending Mar-18 1 0 4 0
Year Ending Mar-19 1 0 4 0
Earnings